Skip to content
GLP-1 Savers
Menu
Ranked #127 · Fair Price

Claya review

Claya is a direct-to-consumer telehealth platform offering compounded semaglutide and tirzepatide in both injectable and oral-tablet forms — a wider format range than most competitors.

Est. first month

From $179/mo (starting dose, compounded)

Save ~87% vs brand-name
Get this deal Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Value Score.
Pricing to watch. The published figure is a starting rate, not a price that is guaranteed at every dose. Confirm the current terms on the provider's own site before you commit.
Semaglutide
From $179/mo (starting dose, compounded)
Tirzepatide
From $279/mo (starting dose, compounded)
Coverage
Coverage not published
Brand-name
Compounded only

The Value Score card

Claya scored on our six published factors. See the methodology.

Lowest Real Price76/100
No Teaser-Rate Bait64/100
Nationwide Availability45/100
Both Molecules98/100
Easy Cancellation95/100
Reputation73/100

Why it's a deal

  • Two named licensed clinicians (Habashy, NMD MS and Barber, MD PhD) — rare transparency for compounded GLP-1
  • Two named pharmacy partners with full addresses (RedRock, UT and Healthware, KY)
  • Both injectable and oral-tablet forms offered for semaglutide and tirzepatide
  • Weight-loss money-back guarantee published on the homepage
  • Free expedited shipping included in the monthly price

Read the fine print

  • States-served list not disclosed — you must check at checkout
  • LegitScript certification status not displayed
  • Corporate legal entity not disclosed on the site or privacy policy
  • Oral compounded tablets have weaker efficacy data than injectable semaglutide
  • Intro pricing is higher at refill ($299), erasing the first-month advantage

The bottom line

Best for: Shoppers who want compounded GLP-1 in injectable and oral-tablet forms with named clinicians. Claya is a direct-to-consumer telehealth platform offering compounded semaglutide and tirzepatide in both injectable and oral-tablet forms — a wider format range than most competitors.

Ranked #127 of 395 programs we track — see our #1 deal, CoreAge Rx, for comparison.

Compare with other deals

The programs scoring closest to Claya, out of 394 others we track.

Shopping Claya against a specific rival? We put it head to head with our top-scoring pick on CoreAge Rx vs Claya, and every program that undercuts or outscores it is ranked on the Claya alternatives board.

More programs we track (24)

364 more are reviewed too — see every GLP-1 program we track, ranked.

Pricing and coverage on this page were read from Claya's own website on ; the Value Score is our editorial judgment per the methodology. “% vs brand-name” compares the lowest disclosed monthly price against a ~$1,349/mo brand-name cash reference. Prices change — confirm on Claya's site. Not medical advice; see our disclosure.

← Back to all deals